La Jolla, CA, United States of America

Fred Princen

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Fred Princen in Diagnosing Irritable Bowel Syndrome

Introduction

Fred Princen is an accomplished inventor based in La Jolla, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in relation to irritable bowel syndrome (IBS). With a total of 8 patents to his name, Princen's work has the potential to improve the accuracy of IBS diagnoses and treatment decisions.

Latest Patents

Among his latest patents, Princen has developed methods for diagnosing IBS through pathway-specific markers. This invention aids in determining whether an individual has IBS while ruling out conditions such as celiac disease and inflammatory bowel disease (IBD). The methods provide an accurate diagnostic prediction of IBS, which is crucial for guiding treatment decisions. Another notable patent involves the use of antibodies to microbiome, stress factors, and mast cell markers as diagnostic markers for IBS. This invention utilizes a statistical algorithm to differentiate between IBS samples and healthy control samples, further enhancing diagnostic accuracy.

Career Highlights

Fred Princen is currently employed at Nestec S.A., where he continues to innovate in the field of medical diagnostics. His work has garnered attention for its potential to transform how IBS is diagnosed and treated.

Collaborations

Princen collaborates with talented individuals such as Sharat Singh and Fabiyola Selvaraj, contributing to a dynamic research environment that fosters innovation.

Conclusion

Fred Princen's contributions to the field of IBS diagnostics exemplify the impact of innovative thinking in medicine. His patents not only enhance diagnostic accuracy but also pave the way for improved treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…